Karyopharm Therapeutics | Rentekostnader

Interest Expense On Debt Endring Dato
AbbVie USD 555M 3M 2023-09
Amgen USD 821M 62M 2023-12
Bristol-Myers Squibb USD 316M 36M 2023-12
Eli Lilly USD 124.6M 4.3M 2023-09
Incyte USD 804K 181K 2023-12
Merck USD 317M 40M 2023-09
Pfizer USD 689M 6M 2023-12
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
TG Therapeutics USD 2.43M 1.28M 2023-12



Karyopharm Therapeutics Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.